Clinical Trial Detail

NCT ID NCT03200847
Title Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

melanoma

Therapies

Pembrolizumab + Tretinoin

Age Groups: adult senior

No variant requirements are available.